Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Enrolling by invitation
Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC
Where
Fuzhou
Age
18 years and over
People
35
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT06816966
No phaseTaking people
Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer
Where
Shanghai
Age
18 years and over
People
50
Run by
Shanghai Chest Hospital
See details and how to joinNCT06818149
No phaseTaking people
Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC
Where
Changsha
Age
18 years and over
People
800
Run by
Hunan Province Tumor Hospital
See details and how to joinNCT04324164
Phase 1Taking people
Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation
Where
Jilin City
Age
18 years to 75 years
People
144
Run by
Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT05504278
Phase 2Not yet taking people in China
Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia
Where
Luoyang, Xinxiang, Zhengzhou
Age
18 years and over
People
250
Run by
Henan Cancer Hospital
See details and how to joinNCT06793228
Phase 2Taking people
Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)
Where
Beijing
Age
18 years and over
People
44
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06793813
No phaseTaking people
Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients
Where
Suzhou
Age
18 years to 80 years
People
50
Run by
Zhao Jun
See details and how to joinNCT06790797
No phaseNot yet taking people in China
The Impact of Thoracic Paravertebral Nerve Block At Different Positions on Pain Relief in Patients Undergoing Single-Port Thoracoscopic Partial Lung Resection
Where
Suzhou
Age
18 years to 70 years
People
200
Run by
Second Affiliated Hospital of Soochow University
See details and how to joinNCT06789276
No phaseNot yet taking people in China
Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure
Where
Zhengzhou
Age
18 years and over
People
55
Run by
Henan Cancer Hospital
See details and how to joinNCT06786208
Phase 2Not yet taking people in China
A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer
Where
Fuzhou, Xiamen
Age
18 years to 75 years
People
34
Run by
Fujian Cancer Hospital
See details and how to joinNCT06786312
Phase 4Not yet taking people in China
Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study
Where
Fuzhou
Age
18 years and over
People
30
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT06785584
No phaseTaking people
Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years and over
People
6,000
Run by
Fudan University
See details and how to joinNCT06684418
Phase 2Not yet taking people in China
Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer
Where
Beijing
Age
18 years to 75 years
People
30
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06784206
No phaseTaking people
A Study on the Efficacy of Atezolizumab Combined with Chemotherapy
Where
Shanghai
Age
18 years and over
People
1,430
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06780826
Phase 2Not yet taking people in China
Adjuvant Treatment of ALK-positive Non-small Cell Lung Cancer with Ensartinib Guided by MRD
Where
Beijing
Age
18 years and over
People
70
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06780839
No phaseTaking people
LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
Where
Guangzhou
Age
18 years to 75 years
People
2,500
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06778512
Phase 1/2Taking people
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
Where
Beijing
Age
18 years to 75 years
People
78
Run by
SUNHO（China）BioPharmaceutical CO., Ltd.
See details and how to joinNCT06581419
Phase 2Taking people
A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
Where
Guangzhou
Age
18 years to 65 years
People
60
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06775275
No phaseTaking people
Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer
Where
Kunming
Age
20 years to 90 years
People
2,000
Run by
First Affiliated Hospital of Kunming Medical University
See details and how to joinNCT06775821
Phase 2Enrolling by invitation
Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer
Where
Nanchang
Age
18 years to 75 years
People
37
Run by
Second Affiliated Hospital of Nanchang University
See details and how to joinNCT06773156
No phaseTaking people
Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-Lung）
Where
Wuhan
Age
18 years and over
People
150
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06500312
No phaseTaking people
To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)
Where
Guangzhou
Age
18 years and over
People
60
Run by
Guangzhou Institute of Respiratory Disease
See details and how to joinNCT06772454
Phase 1Taking people
A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
Where
Wuhan
Age
18 years and over
People
48
Run by
Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06768151
No phaseNot yet taking people in China
The Accuracy of Targeted Lymph Node Dissection of Non-small Cell Lung Cancer Patients According to Predictive Models
Where
Wuhan
Age
18 years to 70 years
People
60
Run by
Zhongnan Hospital
See details and how to joinNCT06768853
Phase 2Taking people
A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC
Where
Chengdu
Age
18 years to 75 years
People
28
Run by
Sichuan University
See details and how to joinNCT06769295